Exclusive: EU to fine Lundbeck, others for blocking generic drugs
By Foo Yun Chee BRUSSELS (Reuters) - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for l...
Read More »
By Foo Yun Chee BRUSSELS (Reuters) - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for l...
Read More »
By Roberta Rampton WASHINGTON (Reuters) - President Barack Obama said on Monday that Americans need to become more open about mental...
Read More »(Reuters) - Gene-based biopharmaceutical company Oxford BioMedica said it put some of its trials on hold, after the company detected...
Read More »
By Dorene Internicola NEW YORK (Reuters) - Cities that provide parks, walking trails, playing fields and running tracks are setting ...
Read More »PARIS (Reuters) - Sanofi has stopped work on two drugs in late-stage development, iniparib and otamixaban, after tests showed both t...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - The number of New York parents who had their child skip at least one required vaccine...
Read More »
By Julie Steenhuysen CHICAGO (Reuters) - A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighti...
Read More »By Julie Steenhuysen CHICAGO (Reuters) - A simple screening program for cervical cancer using vinegar and visual exams helped reduce...
Read More »By Bill Berkrot (Reuters) - Roche Holding AG's drug Avastin helped prolong the lives of women with advanced cervical cancer when add...
Read More »By Deena Beasley CHICAGO (Reuters) - Breast cancer is less likely to recur if women previously treated for the disease take the drug...
Read More »